The effect of ferricion on the differentiation of osteoclast and bone resorption

National Medical Journal of China

Volumn 92, Issue 31, 2012, Pages 2214-2218

  Jia, Peng ^a   He, Yin Feng ^a   Gao, Chao ^a   Du, Hou Bing ^b   Hu, Zhi Yong ^b   Feng, Xiao Qing ^b   Li, Bing Yan ^b   Zhang, Zeng Li ^b   Xv, You Jia ^a   Lin, Hua ^b  

^a SOOCHOW UNIVERSITY   (China)

^b NONE

Author keywords

Ion; Osteoclast; Osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CARBOXY TERMINAL TELOPEPTIDE; CATHEPSIN K; FERRIC AMMONIUM CITRATE; FERRITIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SODIUM CHLORIDE; TRANSCRIPTION FACTOR NFAT; ACID PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; FERRIC ION; ISOENZYME; NFATC1 PROTEIN, MOUSE; PEPTIDE; QUATERNARY AMMONIUM DERIVATIVE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ARTICLE; BONE DENSITY; BONE MARROW CELL; CELL COUNT; CELL STIMULATION; CONCENTRATION (PARAMETERS); DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR; IN VITRO STUDY; IN VIVO STUDY; IRON OVERLOAD; LUMBAR VERTEBRA; MACROPHAGE; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; OSTEOCLAST;

ACID PHOSPHATASE; ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE I; FERRIC COMPOUNDS; ISOENZYMES; MACROPHAGES; MICE; MICE, INBRED ICR; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OSTEOPROTEGERIN; PEPTIDES; QUATERNARY AMMONIUM COMPOUNDS; RANK LIGAND;

EID: 84869211391     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.31.017     Document Type: Article

References (14)

1. Weinberg. Iron loading: a risk factor for osteoporosis. Biometals, 2006, 19: 633-635.
2. Yang Q, Jian J, Abramson S B, et al. Inhibitory effects of iron on bone morphogenetic protein-2-induced osteoblastogenesis. J Bone Miner Res, 2011, 26: 256-259.
3. Zarjou A, Jeney V, Arosio P, et al. Ferritin Ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res, 2010, 25: 164-172.
4. Liu G, Men P, Kenner G H, et al. Age-associtated iron accumulation in bone: implication for postmenopausal osteoporosis and a new target for prevention and treatment by chelation. Biometals, 2006, 19: 245-251.
5. Ishii K, Fumoto T, Iwai K, et al. Coordination of PGC-1b and iron uptaken mitochondrial biogenesis and osteoclast activation. Nat Med, 2009, 15: 259-266.
6. 2010, 90: 2282-2285.
7. Tsay J, Yang Z, Ross F P, et al. Bone loss due to iron overload in a murine model: importance of oxidative stress. Blood, 2010, 116: 2582-2589.
8. Jian J, Pelle E, Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women?. Antioxid Redox Signal, 2009, 11: 2939-2943.
9. Xu Y J, Sirois P, Li K. Iron overload plays a unique role in osteoporosis. Blood, 2010, published online September 9.
10. Isomura H, Fujie K, Shibata K, et al. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology, 2004, 197: 93-100.
11. Regimi A, Fuson T, Yang X, et al. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation. Bone, 2005, 36: 284-291.
12. Yang C R, Lai C C. Thiazolidinediones inhibit TNF-alpha-mediated osteoclast differentiation of RAW264.7 and mouse bone marrow cells through downregulation of NFATc1. Shock, 2010, 33: 662-667.
13. Boyle W J, Simonet W S, Lacey D L. Osteoclast differentiation and activation. Nature, 2003, 423: 337-342.
14. 2005, 85: 721-732.